MicroRNA Expression and Response to Sorafenib, Cytarabine, and Idarubicin in Patients with Acute Myeloid Leukemia

被引：0
|
作者：
Powers, M. P.
Rushton, J. R.
Yao, H.
Barkoh, B. A.
Jones, D.
Luthra, R.
机构：
[1] BCM, Houston, TX USA
[2] MDACC, Houston, TX USA
来源：
MODERN PATHOLOGY | 2010年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1904
引用
收藏
页码：427A / 427A
页数：1
相关论文
共 50 条
  • [21] Idarubicin and cytarabine with and without midostaurin for FLT3-mutated acute myeloid leukemia
    Diebold, Kendall
    Bourne, Garrett
    Espinoza-Gutarra, Manuel
    Al-Kadhimi, Zaid
    Bachiashvili, Kimo
    Rangaraju, Sravanti
    Vachhani, Pankit
    Bhatia, Ravi
    Jamy, Omer
    LEUKEMIA & LYMPHOMA, 2024, 65 (11) : 1737 - 1739
  • [22] Idarubicin and Cytarabine with and without Midostaurin for FLT3-Mutated Acute Myeloid Leukemia
    Diebold, Kendall
    Worth, Sarah
    Bachiashvili, Kimo
    Vachhani, Pankit
    Rangaraju, Sravanti
    Espinoza-Gutarra, Manuel
    Al-Kadhimi, Zaid
    Bhatia, Ravi
    Jamy, Omer
    BLOOD, 2023, 142
  • [23] Efficacy and Toxicity of Induction Therapy with Cladribine, Idarubicin, and Cytarabine (IAC) for Acute Myeloid Leukemia
    Woelich, Susan K.
    Braun, James T.
    Schoen, Martin W.
    Ramlal, Reshma
    Freter, Carl E.
    Petruska, Paul J.
    Lionberger, Jack M.
    ANTICANCER RESEARCH, 2017, 37 (02) : 713 - 717
  • [24] FLUDARABINE, CYTARABINE AND IDARUBICIN FOR INDUCTION TREATMENT OF POOR-RISK ACUTE MYELOID LEUKEMIA
    Villa, M. R.
    Izzo, G. Nitrato
    Gagliardi, A.
    Improta, S.
    Mastrullo, L.
    HAEMATOLOGICA, 2015, 100 : 81 - 81
  • [25] RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia
    Abraham, Ajay
    Varatharajan, Savitha
    Karathedath, Sreeja
    Philip, Chepsy
    Lakshmi, Kavitha M.
    Jayavelu, Ashok Kumar
    Mohanan, Ezhilpavai
    Janet, Nancy Beryl
    Srivastava, Vivi M.
    Shaji, Ramachandran V.
    Zhang, Wei
    Abraham, Aby
    Viswabandya, Auro
    George, Biju
    Chandy, Mammen
    Srivastava, Alok
    Mathews, Vikram
    Balasubramanian, Poonkuzhali
    PHARMACOGENOMICS, 2015, 16 (08) : 877 - 890
  • [26] Adaptive randomized study of idarubicin and cytarabine versus troxacitabine and cytarabine versus troxacitabine and idarubicin in untreated patients 50 years or older with adverse karyotype acute myeloid leukemia
    Giles, FJ
    Kantarjian, HM
    Cortes, JE
    Garcia-Manero, G
    Verstovsek, S
    Faderl, S
    Thomas, DA
    Ferrajoli, A
    O'Brien, S
    Wathen, JK
    Xiao, LC
    Berry, DA
    Estey, EH
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (09) : 1722 - 1727
  • [27] Preclinical evaluation of sorafenib in combination with cytarabine and clofarabine in acute myeloid leukemia (AML)
    Hu, Shuiying
    Niu, Hongmei
    Orwick, Shelley
    Rubnitz, Jeffrey
    Schuetz, John
    Baker, Sharyn D.
    BLOOD, 2007, 110 (11) : 118B - 118B
  • [28] Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia
    Nazha, Aziz
    Kantarjian, Hagop
    Ravandi, Farhad
    Huang, Xuelin
    Choi, Sangbum
    Garcia-Manero, Guillermo
    Jabbour, Elias
    Borthakur, Gautam
    Kadia, Tapan
    Konopleva, Marina
    Cortes, Jorge
    Ferrajoli, Alessandra
    Kornblau, Steve
    Daver, Naval
    Pemmaraju, Naveen
    Andreeff, Michael
    Estrov, Zeev
    Du, Min
    Brandt, Mark
    Faderl, Stefan
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (11) : 961 - 966
  • [29] ORAL IDARUBICIN AND LOW-DOSE CYTARABINE AS THE INITIAL TREATMENT OF ACUTE MYELOID-LEUKEMIA IN ELDERLY PATIENTS
    HAROUSSEAU, JL
    HUGUET, F
    REIFFERS, J
    COLLOMBAT, P
    KOHSER, P
    LEPRISE, PY
    SOUTEYRAND, P
    HURTELOUP, P
    LEUKEMIA & LYMPHOMA, 1991, 5 (2-3) : 145 - 149
  • [30] Pilot study of Mylotarg, idarubicin and cytarabine combination regimen in patients with primary resistant or relapsed acute myeloid leukemia
    Yesid Alvarado
    Apostolia Tsimberidou
    Hagop Kantarjian
    Jorge Cortes
    Guillermo Garcia-Manero
    Stefan Faderl
    Deborah Thomas
    Elihu Estey
    Francis J. Giles
    Cancer Chemotherapy and Pharmacology, 2003, 51 : 87 - 90
12345